We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know
Read MoreHide Full Article
Veeva Systems (VEEV - Free Report) closed at $273.25 in the latest trading session, marking a -3.08% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.73%. On the other hand, the Dow registered a gain of 0.49%, and the technology-centric Nasdaq increased by 1.19%.
The stock of provider of cloud-based software services for the life sciences industry has fallen by 0.86% in the past month, leading the Medical sector's loss of 3.74% and undershooting the S&P 500's gain of 0.55%.
Market participants will be closely following the financial results of Veeva Systems in its upcoming release. The company's upcoming EPS is projected at $2.33, signifying a 14.22% increase compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $933.79 million, up 15.11% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $9.22 per share and revenue of $3.69 billion, which would represent changes of +13.83% and +15.35%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Veeva Systems. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. As of now, Veeva Systems holds a Zacks Rank of #3 (Hold).
Digging into valuation, Veeva Systems currently has a Forward P/E ratio of 30.58. This represents a discount compared to its industry average Forward P/E of 31.16.
Also, we should mention that VEEV has a PEG ratio of 0.87. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical Info Systems was holding an average PEG ratio of 3.11 at yesterday's closing price.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 87, putting it in the top 36% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know
Veeva Systems (VEEV - Free Report) closed at $273.25 in the latest trading session, marking a -3.08% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.73%. On the other hand, the Dow registered a gain of 0.49%, and the technology-centric Nasdaq increased by 1.19%.
The stock of provider of cloud-based software services for the life sciences industry has fallen by 0.86% in the past month, leading the Medical sector's loss of 3.74% and undershooting the S&P 500's gain of 0.55%.
Market participants will be closely following the financial results of Veeva Systems in its upcoming release. The company's upcoming EPS is projected at $2.33, signifying a 14.22% increase compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $933.79 million, up 15.11% from the year-ago period.
For the full year, the Zacks Consensus Estimates are projecting earnings of $9.22 per share and revenue of $3.69 billion, which would represent changes of +13.83% and +15.35%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Veeva Systems. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. As of now, Veeva Systems holds a Zacks Rank of #3 (Hold).
Digging into valuation, Veeva Systems currently has a Forward P/E ratio of 30.58. This represents a discount compared to its industry average Forward P/E of 31.16.
Also, we should mention that VEEV has a PEG ratio of 0.87. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. The Medical Info Systems was holding an average PEG ratio of 3.11 at yesterday's closing price.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 87, putting it in the top 36% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.